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Prevention and treatment of drug-induced renal injury (DIRI) rely on the availability of
sensitive and specific biomarkers of early kidney injury and predictive animal models of
human pathophysiology. This study aimed to evaluate the potential of zebrafish larvae as
translational model in metabolic profiling of DIRI. Zebrafish larvae were exposed to the
lethal concentration for 10% of the larvae (LC10) or 1/2 LC10 of gentamicin, paracetamol
and tenofovir as tenofovir disoproxil fumarate (TDF) and tenofovir (TFV). Metabolites
were extracted from whole larvae and analyzed by liquid chromatography-mass
spectrometry. Principal component analysis showed that drug exposition to the LC10
of paracetamol, TFV, and TDF was the main source of the variance of the data. To
identify the metabolites responsible for the toxic effects of the drugs, partial least
squares discriminant analyses were built between the LC10 and 1/2 LC10 for each drug.
Features with variable importance in projection> 1.0 were selected and Venn diagrams
were built to differentiate between the common and drug specific metabolites of DIRI.
Creatine, tyrosine, glutamine, guanosine, hypoxanthine were identified as common
metabolites, adenosine and tryptophan as paracetamol-specific and xanthine and
oxidized glutathione as tenofovir-specific. Those metabolic changes can be associated
with alterations in energy metabolism, xenobiotic detoxification and protein catabolism,
all described in the human pathophysiology of DIRI. Thus, zebrafish proved to be
a suitable model to characterize the metabolic changes associated with DIRI. This
information can be useful to early diagnose DIRI and to improve our knowledge on
the mechanisms of DIRI.
Keywords: translational models, zebrafish, metabolomics, renal tubular toxicity, mitochondria, kidney injury
biomarkers
Abbreviations: DIRI, drug-induced renal injury; LC10, lethal concentration for 10% of the population; PCA, principal
component analysis; PLS-DA, partial least square – discriminant analysis; QC, quality control; RPLC-Q-TOF, reverse phase
liquid chromatography – quadruple – time of flight; TDF, tenofovir disoproxil fumarate; TFV, tenofovir.
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INTRODUCTION
Drug toxicity is the principal cause of attrition during drug
development (Waring et al., 2015) and is one of the leading
causes of morbidity and mortality (Pirmohamed et al., 2004). In
particular, DIRI is responsible for 19–25% of all cases of acute
kidney injury (Mehta et al., 2004). The kidney is one of the
principal targets of drug toxicity but the current tests to measure
renal function such as serum creatinine and blood urea nitrogen
are not sensitive enough to detect early kidney injury (Slocum
et al., 2012). Therefore, novel screening tools complementary to
traditional biomarkers are of utmost importance. Furthermore, a
better understanding of the pathophysiology of DIRI is critical
for uncovering new therapeutic strategies that may prevent or
modify the disease progression.
There are two main reasons for the increasing interest
of toxicologists in metabolomics. Firstly, metabolomics can
be used to find signatures of toxicity that can be useful
as diagnostic biomarkers and/or to predict toxicity during
drug development. Secondly, metabolomics can improve our
understanding on the mechanisms of drug toxicity through the
identification of the cellular pathways that are affected by the
toxicants (Bouhifd et al., 2013). The COMET and MetaMap R©Tox
projects are two examples of the potential of toxicometabolomics
as a drug toxicity screening tool. Those studies generated
metabolic databases from urine and plasma samples of rats
exposed to different toxicants that were further used to predict
specific organ toxicity, including DIRI (Ebbels et al., 2007; van
Ravenzwaay et al., 2012; Mattes et al., 2013). Toxicometabolomics
proved also to be useful to identify new biomarkers and/or
elucidate the mechanisms underlying DIRI. Most of the studies
evaluated cisplatin or gentamicin-associated tubular toxicities.
The metabolites that were commonly affected were characteristic
of Fanconi’s syndrome (amino acids, glucose, phosphates),
tricarboxylic acid cycle metabolites and tryptophan metabolites
(Lenz et al., 2005; Xu et al., 2008; Boudonck et al., 2009; Zhang
et al., 2016). Interestingly, some of the identified metabolites
preceded the changes in serum creatinine levels, which illustrates
the predictive power of metabolomics in detecting early renal
insult (Portilla et al., 2006).
The bulk of the toxicity data was obtained using murine
models. Zebrafish larvae are a strong alternative animal
model because of their numerous advantageous features such
as rapid development, small size, easy and fast chemical
administration, transgenic capabilities, low financial cost and
high-throughput capabilities (McGrath and Li, 2008; Peterson
and Macrae, 2012). The feasibility of zebrafish larvae for
the evaluation of DIRI has recently been demonstrated.
A detailed analysis on the functional and morphological
renal alterations induced by gentamicin, paracetamol and
tenofovir in zebrafish larvae showed tubular alterations similar
to those described in man. In addition, electron microscopy
revealed that tubular mitochondria were affected by the tested
drugs, which points to severe metabolic alterations (Gorgulho
et al., 2018). This evidence led us to hypothesize that
zebrafish larvae are an attractive model for toxicometabolomics
studies.
To test this hypothesis, an untargeted metabolomics study
was herein performed in zebrafish larvae exposed to drugs with
different mechanisms of nephrotoxicity. The present study gives
for the first time a comprehensive evaluation of the metabolic




All procedures involving zebrafish were approved by the
Ethical Committee of the Instituto Gulbenkian de Ciência
(IGC) number A001.2014, according with the directives from
Direcção Geral Veterinária (Portaria n◦ 1005/92 de 23 de
Outubro).
Zebrafish Larvae
We used the zebrafish line Tg(wt1b:GFP, cdh17:GFP); mitfa−/−;
roy−/+ or +/+ because it was the one that was previously used
to define the lethality curves and characterize the renal tubular
effects of gentamicin, paracetamol, and tenofovir (Gorgulho
et al., 2018). Drug susceptibility might change among different
zebrafish lines. Thus, using a different zebrafish line (i.e., wild-
type zebrafish) would have implied the use of more animals
to define the new lethality curves and to characterize the renal
damage. In order to reduce the number of animals (one of the
three Rs of the Good Animal Practices in Science), we decided
to use the zebrafish line that was previously associated with a
phenotype of DIRI at the concentrations used in this study.
Three aquariums of 10 male and 10 female adult zebrafish were
grown at the CEDOC Fish Facility of the NOVA Medical School,
Lisbon, Portugal. Male and female fish from each aquarium were
mated once per week according to the protocols of the Fish
Facility. Embryos were grown at 28◦C in standard E3 solution
plus 10 mM HEPES buffer till 4 days post fertilization (dpf),
time point at which zebrafish pronephros is completely mature
(Kramer-Zucker et al., 2005).
Drugs
Three drugs known to cause tubular damage in man and proved
to cause renal damage in zebrafish larvae by us and others were
tested (Hentschel et al., 2005; Peng et al., 2010; Rider et al., 2012;
Cianciolo Cosentino et al., 2013; Westhoff et al., 2013; Gorgulho
et al., 2018): gentamicin sulfate, paracetamol (Sigma-Aldrich)
and tenofovir (Sequoia Research Products, United Kingdom).
Tenofovir was administered as the prodrug tenofovir disoproxil
fumarate (TDF) and as tenofovir (TFV), the form of the drug that
is present in the blood after TDF hydrolysis by esterases.
Stock solutions were prepared for all drugs at solubility
concentrations: gentamicin 5,000 µg·mL−1, paracetamol
12,000 µg·mL−1, TDF 6,000 µg·mL−1 and TFV 5,000 µg·mL−1.
All drugs except TFV were dissolved in sterile distilled water.
TFV was prepared in embryo media. All stock solutions were
aliquoted and stored at−20◦C until further use.
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Drug Administration and Sampling
Fifty zebrafish larvae of 4 dpf were transferred to each well of
six-well plates. Embryo media was completely removed from
each well and immediately after that, specific volumes of embryo
media and drug stock solution or drug vehicle (negative controls)
were added to each well to achieve the desired drug concentration
(total volume per well = 8.75 mL).
Drugs were delivered into the embryo media at two different
concentrations: lethal concentration for 10% of the zebrafish
larvae (LC10) associated with functional and/or morphological
damage in our previous study (Gorgulho et al., 2018), and a
non-lethal concentration equal to 1/2 of LC10. To confirm the
LC10 concentrations, three concentrations close to the original
LC10 values were tested for each drug in 10 zebrafish larvae
in triplicate. The new LC10 were not different from the ones
used in our previous article (Gorgulho et al., 2018). In ascending
order, the LC10 were: 521 µM for gentamicin, 2,676 µM for TDF,
9,400 µM for TFV and 19,185 µM for paracetamol.
All experiments were performed in 5–10 replicates during 17
consecutive days. One negative control was always run in parallel
in the same plate to check the viability of the zebrafish larvae. The
volume of drug vehicle that was added to each negative control
was equivalent to the volume of the corresponding drug stock
solution. In this way, negative controls were named as controls
LC10 when they received the same volume of drug vehicle as
LC10 positive samples and controls 1/2 LC10 when they received
the same volume of drug vehicle as 1/2 LC10 positive samples. The
lethality of negative controls was always 0%.
Upon 24 h of drug exposure, dead larvae were discarded
and 40 larvae were transferred from each well to a clean
microcentrifuge tube. Larvae were immediately washed four
times with cold water to remove drugs and/or drug metabolites.
After that, larvae were euthanized by rapid chilling to remove
all remaining embryo media before snap freezing in liquid
nitrogen to quench any enzymatic activity. A total of 83 samples
were stored at −20◦C till extraction (n = 10 gentamicin LC10,
n = 10 gentamicin 1/2 LC10, n = 10 paracetamol LC10, n = 10
paracetamol 1/2 LC10, n = 10 TDF LC10, n = 10 TDF 1/2 LC10,
n = 5 TFV LC10, n = 5 TFV 1/2 LC10, n = 6 negative controls
LC10, n = 7 negative controls 1/2 LC10).
Metabolite Extraction and LC-MS
Acquisition
Samples were randomized before extraction. All samples were
extracted on the same day in four blocks of 17–24 samples
each one. Metabolite extraction from whole zebrafish larvae
was performed with methanol:water (Huang et al., 2013).
Briefly, 350 µL of cold methanol:water 2:1 were added to each
microcentrifuge tube containing 40 larvae of zebrafish. Each
sample was vortexed for 3 min and placed in the ultrasound for
15 min at 4◦C to enhance metabolite extraction. Then, samples
were centrifuged for 10 min at maximum speed and 140 µL
of the supernatant was transferred to a new microcentrifuge
tube for dry-vacuum. Dried samples were reconstituted with
70 µL of water. 10 µL of each reconstituted sample were
pooled (quality control pool; QC pool) and injected throughout
sample acquisition to check the performance of the LC-MS.
55 µL of each sample or QC pool were injected into the RPLC-
Q-TOF (Ultimate 3000 RS tandem Ultra High Performance
Chromatography system, Dionex, Amsterdam, Netherlands;
Electrospray Ionization – Ultra High Resolution -Time of
Flight maXis, Bruker Daltonics, Bremen, Germany). The details
of the RPLC-Q-TOF method have previously been reported
(Nevedomskaya et al., 2011; Pacchiarotta et al., 2012).
Pre-processing of LC-MS Data
Pre-processing of raw data from 83 samples and 12 QC pools
consisted of alignment of retention time, peak picking, peak
matching, filtering and normalization.
Retention time was aligned using the msalign package with a
mass error of 5 ppm (Nevedomskaya et al., 2009). Peak picking
and peak matching were done using the XCMS package (Smith
et al., 2006). The values of the parameters for peak picking
were: mass error = 5 ppm, S/N = 10, Noise = 15,000, peak
width = 5–20s, prefilter = 2, 15,000 and scan range = 30–420s. The
values of the parameters for peak matching were bandwidth = 2,
presence of the peak in all QC pools and m/z width = 0.1.
A final filter was applied to keep only those features with
a relative standard deviation≤ 0.3 among the QC pool. The
final list contained 445 features. Data was normalized by total
area followed by probabilistic quotient normalization (Dieterle
et al., 2006). Data was centered and unit variance scaled before
statistical analysis.
Exclusion of Exogenous Compounds
The signals from exogenous compounds (HEPES and drug
related compounds) were clearly seen in the chromatograms.
Those signals were excluded from the list of 445 features with
the following strategy: (1) exclusion of those ions matching the
theoretical m/z and isotope patterns of HEPES and drug related
compounds (more details in our previous article) (Gorgulho
et al., 2018); (2) exclusion of those features highly correlated
(coefficient of correlation ≥ 0.9) with the features excluded in
the 1st step. The 2nd step assures the complete exclusion of
adducts (i.e., with Na+ or K+), fragments and isotopes from all
exogenous compounds from the list of 445 features.
Statistical Analysis
Multivariate analysis was performed using principal component
analysis (PCA) with R (Team RDC, R Foundation for Statistical
Computing). Classifiers of drug toxicity were selected using
partial least square – discriminant analysis (PLS-DA) with
SIMCA 12+ software package (Umetrics, Umeå, Sweden).
Metabolite Identification
Metabolites annotation was carried out according to the
guidelines for the minimal reporting standards (Sumner et al.,
2007). The Smart Formula tool within the Data Analysis
software (version 4.1) was used for the initial ion annotation
based on accurate mass (mass error< 5 ppm) and isotopic
distribution (sigma value< 20). The results were matched
against online metabolomics databases (METLIN, Human
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Metabolome Database, MassBank). Hits were confirmed with
MS–MS experiments of the sample with the highest intensity
for each of the putative metabolites and the reference standards.
MS–MS experiments were performed on the same RPLC-Q-TOF
instrument in auto MS–MS mode.
RESULTS
Quality of the Data
After LC-MS data pre-processing, the first step in any
metabolomics experiment is to analyze the quality of the data.
This step checks if analytical factors related for example with
sample collection, metabolite extraction or sample acquisition
have any influence in the metabolic profile. PCA is a very
useful method to address this question because it allows
to identify the variables that are responsible for the main
differences among samples in an unbiased fashion. Thus, a
PCA model was built with all the samples and the QC pools
that were repeatedly injected throughout the data acquisition
(Figure 1A). The clustering of the QC pools indicates there are
no metabolic differences among QC pools and thus, proves the
good performance of the LC-MS. The first two components of
the PCA covered 59% of the variance in the data.
Then, a PCA model was built without the QC pools to check
the influence of two other analytical factors: the chromatographic
column and the metabolite extraction. Our LC method uses
two analytical columns that work alternatively to speed up the
acquisition (Nevedomskaya et al., 2011; Pacchiarotta et al., 2012).
Thus, potential differences between columns might have an
influence in the data. Regarding the metabolite extraction, since
samples were organized in four groups or blocks of extraction,
it was important to check if there were metabolic differences
among those blocks. The first two components of the new PCA
model explained 60% of the variance in the data. The score
plot was colored according to the chromatographic column or
extraction block. The column did not influence the distribution
of the samples (Figure 1B). However, the extraction block had
an important influence: samples extracted in the first block
appeared far away from the samples extracted in the fourth block
(Figure 1C).
The influence of the extraction block might interfere with
the effects of the drugs on the metabolic profile, the aim of this
study. Thus, the following strategy was adopted to correct the
FIGURE 1 | Quality of the data. (A) Score plot of the PCA of the 95 samples that were analyzed (zebrafish samples, n = 83, QC pool, n = 12). First two components
covered 47 and 12% of the variation of the data, respectively. (B) Score plot of the PCA of the 83 zebrafish samples showing the influence of the chromatographic
column. First two components covered 48 and 12% of the variation of the data, respectively. (C) Score plot of the PCA of the 83 zebrafish samples showing the
influence of the extraction block. (D) Score plot of the PCA after correction for the influence of the extraction block. First two components cover 46 and 8% of the
variation of the data, respectively.
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effect of the extraction block considering that not all variables
were equally affected and all different conditions (drug and
concentration) were present in all extraction blocks. For each
variable, both the mean per extraction block (block mean) and
the total mean (overall mean) were calculated. A correction factor
was then calculated as the quotient block mean/overall mean.
Following this strategy, the correction factor was different for
each variable (and for each extraction block). After applying
the correction factor, the influence of the extraction was no
longer visible in the PCA (Figure 1D). The first two components
explained 54% of the variance of the data.
Influence of the Drug and Concentration
on the Metabolic Profile
To evaluate if drugs had any influence on the metabolic profile,
previous PCA scores plots representing the 83 samples were
characterized according to the drug and the concentration. PCA
showed a clear effect of the drugs with or without correcting
for the influence of the extraction (Figures 2A,B). Zebrafish
larvae exposed to paracetamol LC10 and 1/2 LC10, TDF LC10
and TFV LC10 were far from the negative controls, while
gentamicin LC10 and 1/2 LC10, TDF 1/2 LC10 and TFV 1/2
LC10 appeared close to the negative controls. This distribution
reflects a concentration dependent effect in the PCA: the lowest
concentrations, corresponding to both 1/2 LC10 and LC10 of
gentamicin and 1/2 LC10 of TDF, were the closest ones to the
negative controls. Only concentrations higher than 2,676 µM,
which corresponds to TDF LC10, showed a different metabolic
profile when compared to the negative controls. The only
exception to this rule was the TFV 1/2 LC10 of 4,700 µM, which
appeared close to the negative controls.
Other interesting effect seen in the score plot of the PCA is
that TDF LC10 and TFV LC10 appeared together separated from
paracetamol, which can reflect the differences in drug related
compounds between the two clusters.
The next step was to exclude all exogenous compounds from
the 445 features. A total of 22 features were excluded and
their m/z corresponded to HEPES and drug related compounds
(Supplementary Table S1). Figure 2C shows the score plot of
a PCA model built after exclusion of these variables. As in
Figure 2B, the only samples that showed a different metabolic
profile from the negative controls, were the ones exposed to LC10
TDF, LC10 TFV, 1/2 LC10 paracetamol and LC10 paracetamol.
One very interesting change was that the differences between
paracetamol and TDF and TFV were no longer visible. Moreover,
the cluster of samples that were grouped with the negative
controls showed more heterogeneity.
Metabolic Markers of Drug Toxicity
Principal component analysis showed a clear influence of the
toxic concentrations of paracetamol, TDF, and TFV on the
metabolic profile (Figures 2A–C). In order to identify the
metabolites related to the toxic effects of the drugs, PLS-DA
was applied with the treatment group as response variable
(Y variable). Paired PLS-DA models were created between
negative controls and 1/2 LC10, negative controls and LC10 and
FIGURE 2 | Influence of drug and concentration on the metabolic profile.
Score plot of the PCA of the 83 zebrafish samples without (A) and with
correction (B) of extraction block effect showing the influence of drug and
concentration. (C) Score plot of the PCA of the 83 zebrafish samples after
correction for the extraction block effect and after exclusion of exogenous
compounds effect showing the influence of drug and concentration. LC10,
lethal concentration for 10% of zebrafish larvae; TDF, tenofovir disoproxil
fumarate; TFV, tenofovir.
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LC10 and 1/2 LC10 for each drug. This approach was chosen since
the interpretation of a two-class PLS-DA model is easier than the
one with multiple classes. As already seen in the PCA, gentamicin
PLS-DA models failed to show any separation between negative
controls, gentamicin LC10 or gentamicin 1/2 LC10 so we decided
to exclude gentamicin samples from the rest of the analysis
(Supplementary Table S2 and Supplementary Figure S1).
In order to reveal the metabolites responsible for the toxic
effects of the drugs, we chose the PLS-DA models between
LC10 and 1/2 LC10 because they are the only ones that can
discriminate between the toxic effects associated with the LC10
in our previous study and the non-lethal effects of 1/2 LC10
considered as non-toxic in this study. From each of the three
PLS-DA models between LC10 and 1/2 LC10, we selected those
features with the variable importance on the projection (VIP)
value> 1.0 on the first component, the one that was responsible
for the separation of the samples (n = 188 for paracetamol,
222 for TDF and 249 for TFV). To differentiate between the
common and drug specific metabolites associated with the toxic
effects of the drugs, we built Venn diagrams with the selected
features. A total of 119 features were common for the three
drugs and 23, 25, and 30 were specific for paracetamol, TDF,
and TFV, respectively. Compound assignment was successful for
nine metabolites: guanosine, hypoxanthine, creatine, glutamine
and tyrosine as common metabolites, adenosine and tryptophan
as metabolites specific of paracetamol toxicity and xanthine
and glutathione disulfide as metabolites specific of TFV toxicity
(Supplementary Table S3 and Supplementary Figure S2).
All metabolites except glutathione disulfide presented higher
concentrations in zebrafish exposed to LC10 than in zebrafish
exposed to 1/2 LC10 (Figure 3 and Supplementary Figure S2).
DISCUSSION
This current study gives for the first time a detailed evaluation
of the metabolic alterations associated with drug-induced renal
tubular injury in zebrafish larvae.
For practical reasons, our experiments were performed on
whole larvae and not on isolated nephrons. Thus, we cannot
exclusively associate the observed metabolic changes with the
renal tubule. Even if all tested drugs affected the renal tubule, it
is possible that they might have also damaged other organs (i.e.,
paracetamol is well known to cause liver toxicity). This plausible
non-renal toxicity does not lessen the power of our approach.
In fact, the kidneys play a key role in the metabolic regulation
of an organism; they control the excretion of metabolic wastes,
the body pH, the extracellular volume and the production and
secretion of hormones. Thus, even at very early stages, kidney
injury might induce not only organ-specific but global metabolic
changes (Lane et al., 2013). Those global metabolic changes
and/or non-renal toxicity-related metabolic changes might also
contribute to DIRI. In this way, our approach, that reflects what
happens in the whole organism, seems to be more valid in terms
of translational model of DIRI.
Our study revealed changes in metabolites of purines,
glutathione and amino acids upon exposure to tubular
neurotoxicants. Similar alterations were also described in
plasma and kidney tissue of rats exposed to different drugs
associated with tubular damage (Boudonck et al., 2009; Zgoda-
Pols et al., 2011; Mattes et al., 2013). Those metabolic changes
can be linked with alterations in energy metabolism, xenobiotic
metabolism and protein catabolism, which have already been
described in the pathophysiology of acute kidney injury (Druml,
2013).
Proximal tubular cells depend on oxidative phosphorylation
to meet the energetic demand of the basolateral Na+/K+
ATPase in the reabsorption of glucose and ions (Basile et al.,
2012). The drugs herein used have been described to induce
tubular mitochondrial swelling and/or cristae fragmentation
in zebrafish larvae (Gorgulho et al., 2018), signs that can
be associated with a functional inhibition of ATP synthesis
(Galloway and Yoon, 2012). The consequent increase in
consumption of ATP, which occurs in parallel with GTP
depletion (Dagher, 2000), might explain the observed increase
in the degradation products of purine nucleotides (adenosine,
guanosine, hypoxanthine and xanthine). In addition, the
depletion of ATP might activate the renal energy deposit
of phosphocreatine. Phosphocreatine works as energy source
facilitating the recycling of ATP (Wyss and Kaddurah-Daouk,
2000), which can be translated into the observed increase in
creatine levels.
On the other hand, the inhibition of oxidative
phosphorylation leads also to a burst of reactive oxygen
species (Adam-Vizi and Chinopoulos, 2006) and a consumption
of antioxidant defenses. A decrease in oxidized glutathione
was observed, which might indicate a decrease in glutathione
synthesis (Santangelo et al., 2004; Shang et al., 2016) or an
increase in conjugation to highly reactive compounds (Wang
and Ballatori, 1998).
Finally, one of the leading metabolic alterations of acute
kidney injury is the activation of protein catabolism with
excessive release of amino acids from skeletal muscle (Flügel-Link
et al., 1983). That might explain the increase observed in some
amino acids in this study (glutamine, tyrosine and tryptophan).
The design of our study that included exposure to lethal
and nonlethal concentrations allowed us to selectively detect
those metabolites associated with the toxic effects of all drugs
except for gentamicin. Zebrafish exposed to both LC10 and 1/2
LC10 of gentamicin had the same metabolic profile as untreated
larvae. In our previous study, zebrafish exposed to the LC10 of
gentamicin experienced renal alterations including a decrease
in the clearance of inulin and mitochondrial morphological
alterations (Gorgulho et al., 2018). However, we reported
difficulties to detect gentamicin in zebrafish larvae and actually
the chromatograms of the whole larvae exposed to gentamicin
or water looked exactly the same (Gorgulho et al., 2018). In
this present work, we do not have other explanation than the
instrumental one to explain this result but we consider important
to report.
Tenofovir was the drug with lowest potency for metabolic
changes. This can be explained by the lower bioavailability of
TFV compared with its prodrug TDF (Shaw et al., 1997). The
low lipophilicity of TFV implies the administration of higher
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FIGURE 3 | Boxplots of the identified metabolites after PLS-DA modeling. Creatine, glutamine, guanosine, hypoxanthine and tyrosine were associated with the renal
tubular toxicity of paracetamol, TDF and TFV. Adenosine and tryptophan were associated with the renal tubular toxicity of paracetamol. Xanthine and glutathione
disulfide were associated with the renal tubular toxicity of TFV. LC10, lethal concentration for 10% of zebrafish larvae; C, control, G, gentamicin; P, paracetamol; TDF,
tenofovir disoproxil fumarate; TFV, tenofovir.
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concentrations of TFV than of TDF to reach similar blood
concentrations.
CONCLUSION
This work demonstrates the usefulness of zebrafish larvae to
characterize the metabolic changes associated with tubular toxic
drugs. Purine metabolites, oxidized glutathione and amino
acids were identified to be associated with the toxic effects
of paracetamol and/or tenofovir. Those metabolites can be
associeted with the pathophysiology of renal tubular injury,
mainly affecting the mitochondria, and might be useful for an
early diagnosis of DIRI, for going deeper in the underlying
mechanisms of DIRI and for screening nephroprotective
compounds.
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